Suggestions
Michael Krupp
Co Founder & CEO at Neurgain Technologies, Inc.
Michael Krupp is a seasoned professional with a diverse background encompassing business development, technology commercialization, and strategic planning in the pharmaceutical and biotechnology sectors.
With a solid educational foundation including a Ph.D. in Biochemistry from the University of Rochester School of Medicine and Dentistry, Michael has honed his skills over the years, holding various key positions in esteemed organizations such as Pfizer, Gen-Probe Incorporated, and Kalos Therapeutics.
His expertise extends to guiding laboratory research, assessing product viability, ensuring regulatory compliance, fostering relationships, negotiating deals, and mentoring entrepreneurs in the industry.
Michael has demonstrated success in leading the development of innovative business models and research programs, culminating in the commercialization of pharmaceutical and biotechnology products.
He also brings a wealth of experience in budgeting, fundraising, proposal development, and team building, all vital components in driving successful ventures in the highly competitive pharmaceutical and biotechnology landscape.
